東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Virus entry inhibitors = stopping th...

Jiang, Shibo.

Linked to FindBook

Google Book

Amazon

博客來

Virus entry inhibitors = stopping the enemy at the gate /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Virus entry inhibitors/ edited by Shibo Jiang, Lu Lu.
Reminder of title:	stopping the enemy at the gate /
other author:	Jiang, Shibo.
Published:	Singapore :Springer Nature Singapore : : 2022.,
Description:	x, 239 p. :ill., digital ;24 cm.
[NT 15003449]:	Peptide virus entry inhibitors: past, present and future -- Small-molecule virus entry inhibitors -- Human endogenous virus entry inhibitors -- Lipopeptide HIV entry inhibitors -- Peptide HIV entry inhibitors targeting gp41 NHR -- Small-molecule HIV entry inhibitors targeting gp41 MPER -- Small-molecule HIV entry inhibitors targeting CD4-binding site in gp120 -- Small-molecule HIV entry inhibitors targeting gp120 -- SARS-CoV, MERS-CoV, and pan-coronavirus entry inhibitors -- Hendra virus (HeV) and Nipah virus (NiV) entry inhibitors -- Ebola virus entry inhibitors -- Cyclo-peptide-based Ebola virus entry inhibitors -- Influenza virus entry inhibitors -- Parainfluenza virus entry inhibitors -- Zika virus entry inhibitors -- HBV entry inhibitors -- HBV and HDV entry inhibitors -- HCV entry inhibitors -- Protein-based HPV entry inhibitors.
Contained By:	Springer Nature eBook
Subject:	Virus inhibitors. -
Online resource:	https://doi.org/10.1007/978-981-16-8702-0
ISBN:	9789811687020

Virus entry inhibitors = stopping the enemy at the gate /
Virus entry inhibitorsstopping the enemy at the gate /[electronic resource] :edited by Shibo Jiang, Lu Lu. - Singapore :Springer Nature Singapore :2022. - x, 239 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v. 13662214-8019 ;. - Advances in experimental medicine and biology ;v. 1366..

Peptide virus entry inhibitors: past, present and future -- Small-molecule virus entry inhibitors -- Human endogenous virus entry inhibitors -- Lipopeptide HIV entry inhibitors -- Peptide HIV entry inhibitors targeting gp41 NHR -- Small-molecule HIV entry inhibitors targeting gp41 MPER -- Small-molecule HIV entry inhibitors targeting CD4-binding site in gp120 -- Small-molecule HIV entry inhibitors targeting gp120 -- SARS-CoV, MERS-CoV, and pan-coronavirus entry inhibitors -- Hendra virus (HeV) and Nipah virus (NiV) entry inhibitors -- Ebola virus entry inhibitors -- Cyclo-peptide-based Ebola virus entry inhibitors -- Influenza virus entry inhibitors -- Parainfluenza virus entry inhibitors -- Zika virus entry inhibitors -- HBV entry inhibitors -- HBV and HDV entry inhibitors -- HCV entry inhibitors -- Protein-based HPV entry inhibitors.

This book focuses on the important discoveries of the small molecule-, peptide-, and protein-based virus entry inhibitors and discusses advance of the development of different type of virus entry inhibitors as a novel class of antiviral drugs for treatment and prevention of viral infection. It includes entry inhibitors of HIV,HeV, NiV, RSV, EBOV, HCoV, HBV, HCV, HDV, HPV, flavivirus and influenza virus, so on. This book aims at providing an updated knowledge on virus entry inhibitors.

ISBN: 9789811687020

Standard No.: 10.1007/978-981-16-8702-0doiSubjects--Topical Terms:

3398919
Virus inhibitors.

LC Class. No.: QR370 / .V57 2022

Dewey Class. No.: 579.2

Virus entry inhibitors = stopping the enemy at the gate /
LDR:02418nmm a2200337 a 4500 001 2299602
003 DE-He213
005 20220419140231.0
006 m d
007 cr nn 008maaau
008 230324s2022 si s 0 eng d
020 $a 9789811687020 $q (electronic bk.)
020 $a 9789811687013 $q (paper)
024 7 $a 10.1007/978-981-16-8702-0 $2 doi
035 $a 978-981-16-8702-0
040 $a GP $c GP
041 0 $a eng
050 4 $a QR370 $b .V57 2022
072 7 $a PSGL $2 bicssc
072 7 $a MED052000 $2 bisacsh
072 7 $a PSG $2 thema
082 0 4 $a 579.2 $2 23
090 $a QR370 $b .V821 2022
245 0 0 $a Virus entry inhibitors $h [electronic resource] : $b stopping the enemy at the gate / $c edited by Shibo Jiang, Lu Lu.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2022.
300 $a x, 239 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 2214-8019 ; $v v. 1366
505 0 $a Peptide virus entry inhibitors: past, present and future -- Small-molecule virus entry inhibitors -- Human endogenous virus entry inhibitors -- Lipopeptide HIV entry inhibitors -- Peptide HIV entry inhibitors targeting gp41 NHR -- Small-molecule HIV entry inhibitors targeting gp41 MPER -- Small-molecule HIV entry inhibitors targeting CD4-binding site in gp120 -- Small-molecule HIV entry inhibitors targeting gp120 -- SARS-CoV, MERS-CoV, and pan-coronavirus entry inhibitors -- Hendra virus (HeV) and Nipah virus (NiV) entry inhibitors -- Ebola virus entry inhibitors -- Cyclo-peptide-based Ebola virus entry inhibitors -- Influenza virus entry inhibitors -- Parainfluenza virus entry inhibitors -- Zika virus entry inhibitors -- HBV entry inhibitors -- HBV and HDV entry inhibitors -- HCV entry inhibitors -- Protein-based HPV entry inhibitors.
520 $a This book focuses on the important discoveries of the small molecule-, peptide-, and protein-based virus entry inhibitors and discusses advance of the development of different type of virus entry inhibitors as a novel class of antiviral drugs for treatment and prevention of viral infection. It includes entry inhibitors of HIV,HeV, NiV, RSV, EBOV, HCoV, HBV, HCV, HDV, HPV, flavivirus and influenza virus, so on. This book aims at providing an updated knowledge on virus entry inhibitors.
650 0 $a Virus inhibitors. $3 3398919
650 0 $a Viruses. $3 571474
650 1 4 $a Virology. $3 642304
650 2 4 $a Medical Microbiology. $3 890951
650 2 4 $a Biomedical Research. $3 851895
700 1 $a Jiang, Shibo. $3 3597248
700 1 $a Lu, Lu. $3 1901389
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Advances in experimental medicine and biology ; $v v. 1366. $3 3597249
856 4 0 $u https://doi.org/10.1007/978-981-16-8702-0
950 $a Biomedical and Life Sciences (SpringerNature-11642)